The full picture of the remarkable uptake of the new generation of hepatitis C drugs and the impact of coverage expansions led by the Affordable Care Act on national health spending for 2014 is now clear.
The dual factors of coverage expansion and rapid growth in retail prescription drug spending led to a much faster rate...